Lupin Ltd. · LUPIN
Every Lupin Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY PHARMA. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
25results judged
1read right
2read wrong
2flat / no call
20unread
32%beat the market
-2.4%avg vs market, 10d
4.8%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| strong | 1 | 1 | 0 | 0 | 100% | +6.5% | |
| favourable | 1 | 0 | 1 | 0 | 0% | -5.6% | |
| neutral | 1 | 0 | 0 | 1 | — | -4.8% | |
| unfavourable | 1 | 0 | 0 | 1 | — | +1.6% | |
| weak | 1 | 0 | 1 | 0 | 0% | +3.5% | |
| unread | 20 | 0 | 0 | 0 | — | -3.1% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
25 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 6 Aug Q1FY27 | — | unread | -3.6% | -7.7% | -6.1% | +2% | no figures |
|
› |
| 7 May Q4FY26 | neutral | neutral | -8.3% | -7.2% | -4.8% | +7% | no figures |
|
› |
| 12 Feb Q3FY26 | strong | right | +0.5% | +4.1% | +6.5% | +5% | no figures |
|
› |
| 6 Nov Q2FY26 | unfavourable | neutral | +1.8% | +3.8% | +1.6% | -2% | no figures |
|
› |
| 5 Aug Q1FY26 | weak | wrong | +4.3% | +5.3% | +3.5% | -3% | no figures |
|
› |
| 14 May Q4FY25 | favourable | wrong | -0.1% | -4.9% | -5.6% | +1% | no figures |
|
› |
| 12 Feb Q3FY25 | — | unread | -0.6% | -8.5% | -6.3% | -12% | no figures |
|
› |
| 7 Nov Q2FY25 | — | unread | -1.3% | -0.2% | -0.3% | -5% | no figures |
|
› |
| 6 Aug Q1FY25 | — | unread | +7.3% | +10.4% | +7.0% | +22% | no figures |
|
› |
| 7 May Q4FY24 | — | unread | -3.8% | +2.2% | +1.5% | +4% | no figures |
|
› |
| 7 Feb Q3FY24 | — | unread | +1.7% | -0.0% | -1.3% | +24% | no figures |
|
› |
| 9 Nov Q2FY24 | — | unread | -2.6% | +2.7% | +0.8% | +9% | no figures |
|
› |
| 3 Aug Q1FY24 | — | unread | +4.4% | +4.9% | +4.9% | +18% | no figures |
|
› |
| 10 May Q4FY23 | — | unread | +2.7% | +4.3% | +4.2% | +15% | no figures |
|
› |
| 9 Feb Q3FY23 | — | unread | -12.8% | -14.9% | -12.5% | +6% | no figures |
|
› |
| 10 Nov Q2FY23 | — | unread | +7.6% | +3.6% | +1.8% | +7% | no figures |
|
› |
| 4 Aug Q1FY23 | — | unread | +6.5% | +8.8% | +8.2% | +2% | no figures |
|
› |
| 19 May Q4FY22 | — | unread | -6.6% | -10.3% | -12.7% | -11% | no figures |
|
› |
| 4 Feb Q3FY22 | — | unread | -10.6% | -14.7% | -13.1% | -0% | no figures |
|
› |
| 28 Oct Q2FY22 | — | unread | +7.1% | +7.1% | +5.7% | -11% | no figures |
|
› |
| 10 Aug Q1FY22 | — | unread | -12.9% | -16.3% | -18.5% | -4% | no figures |
|
› |
| 13 May Q4FY21 | — | unread | -1.9% | -0.3% | -5.3% | +22% | no figures |
|
› |
| 29 Jan Q3FY21 | — | unread | -5.8% | +0.3% | -9.4% | +9% | no figures |
|
› |
| 5 Nov Q2FY21 | — | unread | -2.9% | -6.4% | -13.6% | -7% | no figures |
|
› |
| 7 Aug Q1FY21 | — | unread | +2.3% | +4.8% | +3.3% | +0% | no figures |
|
› |